13-cis-retinoic acid in the treatment of oral leukoplakia.
about
Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta analysisCactus pear: a natural product in cancer chemopreventionMolecular cloning and characterization of a novel retinoic acid-inducible gene that encodes a putative G protein-coupled receptorRetinoids for preventing the progression of cervical intra-epithelial neoplasiaRetinoids for preventing the progression of cervical intra-epithelial neoplasiaInterventions for treating oral leukoplakiaUpdated Physician's Guide to the Off-label Uses of Oral IsotretinoinOral carcinogenesis and oral cancer chemoprevention: a reviewThe proteosome inhibitor MG132 attenuates retinoic acid receptor trans-activation and enhances trans-repression of nuclear factor kappaB. Potential relevance to chemo-preventive interventions with retinoidsMolecular cancer prevention: Current status and future directionsOral premalignancy: the roles of early detection and chemopreventionImpaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma.Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cellsRetinoic acid actions through mammalian nuclear receptors.Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinicExpression of RARalpha and RARbeta in human oral potentially malignant and neoplastic lesions.Although leukoplakia responds to some treatments relapses and adverse effects are common.Retinoids: present role and future potential.RETRACTED: Novel management of oral cancer: a paradigm of predictive oncology.Combination of physical activity, nutrition, or other metabolic factors and vaccine responseA comparative evaluation: Oral leukoplakia surgical management using diode laser, CO2 laser, and cryosurgery.Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents.Mortality in the randomized, controlled lung intergroup trial of isotretinoinPPARĪ³ in head and neck cancer preventionChemoprevention of head and neck cancer.Cancer chemoprevention: present status, future expectations.The molecular biology of mucosal field cancerization of the head and neck.Retinoids and ovarian cancer.New therapeutic strategies for the treatment and prevention of head and neck cancer.High-dose fenretinide in oral leukoplakia.Systemic oral isotretinoin therapy and flow rate, pH, and matrix metalloproteinase-9 activity of stimulated saliva.Inhibition of cyclooxygenase-2: an approach to preventing cancer of the upper aerodigestive tract.Interventions for treating oral leukoplakia to prevent oral cancer.Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesionsCyclin D1 and cancer development in laryngeal premalignancy patients.Prospects for chemoprevention of cancer.Understanding carcinogenesis for fighting oral cancer.Roles of retinoids and their nuclear receptors in the development and prevention of upper aerodigestive tract cancersInhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma.Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer.
P2860
Q21089955-1017AF1F-23D5-45FD-91B8-73D876CD53F7Q21245909-2142F25C-925E-4EB1-BD6D-E5827BFB7389Q22008554-49D0AE35-E905-48DF-A551-6F56B8A37409Q24202103-BE6FD05E-551D-489E-A4B4-EE3A10C238CAQ24242874-18657108-5F86-459C-BECF-BAA02E95BC06Q24243783-391BB987-8A8E-4BC1-B780-5F1B039E5482Q24568006-CBCDE2A0-8A91-4AAE-A67B-8DB3EA3AACBBQ24624581-16A864C9-D87B-423D-8015-EAC15A12C4AAQ24792397-BD5FA76D-E275-45D3-8A26-C2C11F2C01B1Q26797207-1B4EC5F5-A34E-4E3E-893C-76AD13E09B19Q27693327-5267F72D-EA6B-40A4-9ED6-766E9F513FF0Q27853287-5E9D4EB4-4BA7-4C65-9B0B-079195477DB7Q28346064-325DAA3C-8D2E-4CB7-B945-169D78AD5515Q30408649-7122C3CF-5DBF-4C15-A114-9FC6A68FE5D1Q30498812-B7566763-A6A2-4A90-8B41-C13EFD06F8A8Q31811674-DCD6DCA0-7DCD-48EF-8007-C289FA293539Q33213190-F4C587BB-EB04-41C7-9037-F24B90336621Q33676667-DDDFF75E-18EF-43F8-B092-0E165E954743Q33723572-D1E72989-9EF2-44FD-91F3-61523C8765FBQ33751144-6990B970-1102-4DE2-B2CF-45CB5A19601AQ33809191-2EE72C00-FB6A-4979-88CC-FAD3494A776DQ33888325-086FC8AC-4FED-41C3-BBFC-195AF358E5F6Q33895618-18624CD3-1F66-4E7A-ADE5-345446B4E6F7Q33896090-14A5F242-F86D-41A9-9B18-FD58F619B79FQ33904774-AFA17277-A309-492E-94EC-DDC3E00FED1AQ33962596-60EB0ACC-6141-458C-BF4E-C2DAABDF7BB2Q33973007-6E245BBB-686E-420A-9909-6043FEF07739Q34002981-D46F9B90-863F-42C0-B597-612E60829CA7Q34090976-A663FAFB-4373-43F6-87CA-E47602E3022BQ34164825-FE75737D-B4E1-4A1E-838A-F6605DB180D8Q34401194-4332B771-BEAF-46B6-AA36-378ACC4375E1Q34497356-FA4C8015-FAAC-4186-96A9-8A65678E354CQ34535749-59FB3B8C-056E-4109-A978-E340EC61DBB5Q34568606-853BB57F-2A1E-4DF3-8B94-8F6B7AF7BF99Q34569485-A44654B8-BD35-4874-9B7D-ACBBA0A99DDFQ34600760-18D763E0-BBBD-40AD-B0A0-86222D8B35CAQ34631085-72620685-6C4A-46CB-9194-3F4706A791FBQ34638808-3DEDF6C4-4BBF-4316-9800-8E4553854D79Q34790902-C3F8EE66-4639-4284-8E9D-D8057E8558E6Q34804039-74818B95-ABBC-42F8-BB4E-20DD5EB3BA5F
P2860
13-cis-retinoic acid in the treatment of oral leukoplakia.
description
1986 nĆ® lÅ«n-bĆ»n
@nan
1986 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« Ō“Õ„ÕÆÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
1986 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ¤Õ„ÕÆÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
1986幓ć®č«ę
@ja
1986幓č«ę
@yue
1986幓č«ę
@zh-hant
1986幓č«ę
@zh-hk
1986幓č«ę
@zh-mo
1986幓č«ę
@zh-tw
1986幓č®ŗę
@wuu
name
13-cis-retinoic acid in the treatment of oral leukoplakia.
@ast
13-cis-retinoic acid in the treatment of oral leukoplakia.
@en
13-cis-retinoic acid in the treatment of oral leukoplakia.
@nl
type
label
13-cis-retinoic acid in the treatment of oral leukoplakia.
@ast
13-cis-retinoic acid in the treatment of oral leukoplakia.
@en
13-cis-retinoic acid in the treatment of oral leukoplakia.
@nl
prefLabel
13-cis-retinoic acid in the treatment of oral leukoplakia.
@ast
13-cis-retinoic acid in the treatment of oral leukoplakia.
@en
13-cis-retinoic acid in the treatment of oral leukoplakia.
@nl
P2093
P1476
13-cis-retinoic acid in the treatment of oral leukoplakia.
@en
P2093
Atkinson EN
Batsakis JG
Endicott J
Fofonoff S
P304
P356
10.1056/NEJM198612113152401
P407
P577
1986-12-01T00:00:00Z